HCA Healthcare Reports Q2 Results; Raises 2021 Guidance

 Key second quarter metrics (all percentage changes compare 2Q 2021 to 2Q 2020 unless otherwise noted):

• Revenues totaled $14.435 billion

• Net income attributable to HCA Healthcare, Inc. totaled $1.450 billion, or $4.36 per diluted share

• Adjusted EBITDA totaled $3.219 billion

• Cash flows from operating activities totaled $2.251 billion

• Same facility admissions increased 17.5 percent and same facility equivalent admissions increased 26.8 percent

2021 Revised Guidance

The 2021 guidance ranges for the year have been revised from our first quarter release and are as follows:

		2021 Guidance Range
Revenues		$57.0 to $58.0 billion
Adjusted EBITDA		$12.10 to $12.50 billion
EPS (diluted)		$16.30 to $17.10 per diluted share
Capital Expenditures		Approximately $3.7 billion

The Company’s 2021 guidance contains a number of assumptions, including, among others, the Company’s current expectations regarding the impact of the COVID-19 pandemic and related government legislation, and excludes the impact of items such as, but not limited to, gains or losses on sales of facilities, losses on retirement of debt, legal claims costs and impairment of long-lived assets.

https://finance.yahoo.com/news/hca-healthcare-reports-second-quarter-113000398.html